Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Berberine ursodeoxycholate (HTD1801) is an orally effective hypolipidemic agent, an ionic salt of Berberine and Ursodeoxycholic acid.Berberine ursodeoxycholate has a wide range of metabolic activity and significantly reduces liver fat content. Berberine ursodeoxycholate has been used in studies of hyperlipidemia, non-alcoholic steatohepatitis (NASH) and diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 32.00 | |
2 mg | In stock | $ 45.00 | |
5 mg | In stock | $ 73.00 | |
10 mg | In stock | $ 118.00 | |
25 mg | In stock | $ 237.00 | |
50 mg | In stock | $ 378.00 | |
100 mg | In stock | $ 569.00 | |
500 mg | In stock | $ 1,190.00 |
Description | Berberine ursodeoxycholate (HTD1801) is an orally effective hypolipidemic agent, an ionic salt of Berberine and Ursodeoxycholic acid.Berberine ursodeoxycholate has a wide range of metabolic activity and significantly reduces liver fat content. Berberine ursodeoxycholate has been used in studies of hyperlipidemia, non-alcoholic steatohepatitis (NASH) and diabetes. |
In vivo | Berberine ursodeoxycholate (BUDCA) tested in this phase 2 study (1000 mg twice a day) results in a significant reduction in liver fat content after 18 weeks of treatment. This improvement in liver fat content is associated with improvement in glycemic control, the apparent improvement in hepatic inflammation and injury with reductions in serum levels of liver associated enzymes, significant weight loss, and modest reductions in serum lipid levels.[1] |
Synonyms | HTD1801, BUDCA |
Molecular Weight | 217.69 |
Formula | C6H8CuN3O2 |
CAS No. | 1868138-66-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 6.9 mg/mL (9.5 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Berberine ursodeoxycholate 1868138-66-2 HTD1801 HTD-1801 BUDCA HTD 1801 inhibitor inhibit